Abstract
Bisphenol A (BPA) is an ubiquitous environmental toxin. This multi-center longitudinal study evaluates the relationship between serum BPA levels, inflammatory biomarkers, and short-term mortality in young patients with intracerebral hemorrhage (YICH) and concurrent thyroid dysfunction. Results indicate that high BPA exposure is a strong predictor of ICH risk and poor prognosis, mediated by an inflammatory response system involving the NF-κB signaling pathway and altered microRNA expression.
Introduction
Intracerebral hemorrhage (ICH) remains a critical challenge in stroke medicine, particularly among younger populations where traditional risk factors may not fully explain the incidence. Recent research has turned toward environmental endocrine disruptors like Bisphenol A (BPA), found in common plastics and food packaging. This study investigates how BPA exposure interacts with thyroid function—specifically Low T3 (LT3) syndrome and sub-clinical hypothyroidism (SCH)—to influence the clinical trajectory of young ICH patients.
Methods
The study enrolled 600 young ICH patients and 600 healthy controls. Patients were stratified by thyroid function into LT3 and SCH subgroups. BPA exposure was estimated through serum analysis and a cumulative quantification of plastic bag usage over a decade. Researchers measured a suite of biomarkers, including thrombin, matrix metalloproteinase-9 (MMP-9), and specific microRNAs (miR-338-3p and miR-451), while monitoring 24-hour ambulatory blood pressure to assess physiological stability.
Results
The BPA-Induced Inflammatory Network
A primary finding of the study is the correlation between serum BPA and a complex network of inflammatory markers. BPA levels were significantly elevated in YICH patients, particularly those in the LT3 group (0.91 ± 0.14 pg/ml) compared to controls (0.535 ± 0.11 pg/ml).
Linear correlation analysis revealed that BPA acts as a trigger for vascular injury and inflammation. It showed strong positive correlations with thrombin (r = 0.55) and MMP-9 (r = 0.51), as well as the pro-inflammatory miR-338-3p (r = 0.46). Conversely, it was negatively correlated with the protective miR-451 (r = -0.52) and serum FT3 (r = -0.51).
BPA as an Independent Risk Factor
Multivariate analysis confirmed that BPA is an independent risk factor for poor outcomes in ICH. After adjusting for confounding variables such as age, gender, and BMI, BPA exposure was associated with a significantly increased risk of hemorrhage and blood pressure instability. Specifically, BPA exposure was linked to higher nocturnal diastolic blood pressure (nDBP), a "non-dipping" pattern that contributes to vascular damage.
The statistical analysis highlighted that the odds ratio (OR) for BPA as a risk factor is 7.413, surpassing other significant markers like thrombin (OR = 5.114) and miR-338-3p (OR = 4.170).
Clinical Outcomes and Mortality
The study observed a clear difference in short-term prognosis based on thyroid status. The 30-day mortality rate was significantly higher in the LT3 group (4.68%) compared to the SCH group (2.5%). This suggests that the combination of high BPA exposure and Low T3 syndrome creates a particularly high-risk profile for young patients.
Conclusion
High BPA exposure strongly predicts the risk and severity of ICH in young patients. By activating the NF-κB signaling pathway and destabilizing blood pressure patterns, BPA fuels an inflammatory response that worsens clinical outcomes. These findings underscore the need for environmental health awareness and suggest that monitoring thyroid function and BPA levels could improve prognostic accuracy in young stroke patients.
Summary updated